If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

3 Sep 2007 07:00

Immunodiagnostic Systems Hldgs PLC03 September 2007 31 August 2007 Immunodiagnostic Systems Holdings PLC("IDS" or the "Group") Completion of Acquisition IDS, a leading producer of diagnostic testing kits, announces the completion ofthe acquisition of 99.93% of the ordinary share capital of Biocode Hycel S.A. ("Biocode"). As previously announced, the initial consideration for Biocode was €23,000,000,with €11,000,000 to be satisfied in cash, and the balance satisfied through theissue of 2,839,719 new Ordinary Shares in IDS, at a price of 216p. A placing of 5,000,000 New Ordinary Shares at a placing price of 240p per shareraised £12,000,000 before expenses to satisfy the cash portion of the initialconsideration and for additional working capital. The Ordinary Shares have been admitted to trading on AIM and Admission becameeffective on 31 August 2007. Following the Admission the Company's issued sharecapital consists of 23,967,686 ordinary shares with a nominal value of 2 penceeach. The Biocode Group is a Belgian-French group that develops, manufactures anddistributes IVD instruments and reagents for immunoassay, haematology and biochemistry. Biocode Hycel S.A. has four sites, namely Liege (Belgium) and Massy, Rennes and Pouilly (France), andcurrently employs 132 people. Biocode Hycel S.A. is in the final stages of developing a new generation ofautomation instruments, called the 3X3 Instrument. As announced on 4 December 2006, IDS already has acontractual working relationship with Biocode Hycel S.A. in that IDS is part of the Alliance thathas been developing tests for this new platform. For the year ending 31 December 2006, Biocode's EBIT was •-2.8m (c. £-1.9m), ona turnover of €12.1m (c. £8.1m). The acquired net assets as at 31 December 2006(adjusted for the elimination of net cash/net debt and the alignment ofaccounting policies) were €3.2m (c. £2.1m). Enquiries: Immunodiagnostic Systems Holdings plc Parkgreen Communications LtdDr. Roger Duggan, Managing Director Ben KnowlesTel: 0191 519 0660 Tel: 020 7851 7480www.idsltd.com ben.knowles@parkgreenmedia.com Landsbanki Securities (UK) LimitedSindre OttesenTel: 0207 426 9000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Jul 20217:00 amRNSCancellation - Immunodiagnostic Systems Hldgs PLC
12th Jul 202111:54 amRNSScheme of Arrangement becomes Effective
12th Jul 20217:30 amRNSSuspension- Immunodiagnostic Systems Holdings PLC
9th Jul 202110:47 amRNSForm 8 (DD) - Immunodiagnostic Systems Hldgs PLC
9th Jul 202110:47 amRNSForm 8 (DD) - Immunodiagnostic Systems Hldgs PLC
8th Jul 20213:13 pmRNSExercise of Options
8th Jul 202111:52 amRNSCourt Sanction of the Scheme of Arrangement
5th Jul 20215:30 pmRNSImmunodiagnostic Systems Hldgs
1st Jul 202111:53 amRNSResults of Court Meeting and General Meeting
22nd Jun 202112:40 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
22nd Jun 20219:22 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Hldgs
22nd Jun 20217:00 amRNSForm 8.3 - Immunodiagnostic
11th Jun 20212:40 pmRNSForm 8.3 - [Immunodiacnostic Systems]
11th Jun 202112:00 pmRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Hldgs
10th Jun 20212:00 pmEQSAmendment of Form 8.3 - Shareholder Value Beteiligungen AG: PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
10th Jun 202111:31 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
9th Jun 202112:12 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings plc
4th Jun 20219:23 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
4th Jun 20218:23 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
3rd Jun 20215:43 pmRNSPublication of Scheme Document
3rd Jun 20217:00 amRNSAdditional Listing to Correct Discrepancy
28th May 20214:13 pmEQSForm 8.3 Immunodiagnostic Systems Holdings PLC
28th May 20213:58 pmEQSForm 8.3 - Shareholder Value Beteiligungen AG: Immunodiagostic Systems Holdings PLC
28th May 20219:33 amEQSForm 8 - Shareholder Value Beteiligungen AG: 8.3 Immunodiagnostic Holding PLC
28th May 20219:26 amEQSShareholder Value Management AG: Form 8.3 Immunodiagnostic Systems Holdings PLC
27th May 20218:57 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
26th May 20219:10 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
25th May 20214:14 pmRNSForm 8.3 - Immunodiagnostic Systems Hldgs PLC
25th May 202110:00 amRNSForm 8.3 - [IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC]
25th May 20218:20 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
24th May 20211:39 pmRNSForm 8 (OPD) - Immunodiagnostic Systems Hldgs PLC
24th May 202110:58 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
21st May 20219:41 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
21st May 20218:37 amRNSForm 8.3 - Immunodiagnostic Systems Hldgs PLC
20th May 202110:49 amRNSForm 8.3 - Immunodiagnostic Systems Holding PLC
20th May 202110:23 amRNSForm 8.3 - [Immunodiagnostic Systems Holding PLC]
20th May 20219:55 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
19th May 20219:58 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
19th May 20219:32 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
18th May 20215:03 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
18th May 20212:33 pmRNSDirector/PDMR Shareholding
18th May 20212:16 pmPRNForm 8.3 - Immunodiagnostic Systems Holdings Plc
18th May 202112:16 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
18th May 20219:16 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
18th May 20218:50 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
17th May 20219:05 amRNSSecond Price Monitoring Extn
17th May 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.